Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...

The success of the Public Offer and the broad participation of the investing public is both a vindication of, and a vote of ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Investors typically celebrate IPOs as milestone moments — and potential exit opportunities — for their startups. In an ...

Snag is, Cheniere’s two export terminals are already advanced enough to generate several billion dollars in cash flow, much of which is already flowing in dividends to shareholders. Venture Global is ...

Metsera, a well-funded biotech trying to angle toward the front of the obesity medicine pack, has proposed a $250 million IPO ...

The 1975 Emergency underscored the need to safeguard rights and uphold democratic checks and balances Erosion of freedoms and ...

Empro Group ( EMPG) has filed and set terms with the SEC to raise up to $5M in an initial public offering. The company plans to offer about 1.3M shares priced between $4.00 to $4.50. Description: ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Czech steam-turbine manufacturer Doosan Skoda Power AS launched an initial public offering, touting an outlook for high ...

Luxury logistics leader Ferrari Group Plc (NYSE:RACE) has announced plans to debut on the Amsterdam Stock Exchange with an ...

Bengaluru-based cloud kitchen startup Curefoods is preparing to launch its $300-400 Mn IPO in the latter half of FY26.